114 related articles for article (PubMed ID: 38841696)
1. Serum neurofilament light chain: a predictive marker for outcomes following mild-to-moderate ischemic stroke.
Xu C; Yi T; Qing T; Jiang Y; Yi X; Xu J; Ma J
Front Neurol; 2024; 15():1398826. PubMed ID: 38841696
[TBL] [Abstract][Full Text] [Related]
2. NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.
Uphaus T; Bittner S; Gröschel S; Steffen F; Muthuraman M; Wasser K; Weber-Krüger M; Zipp F; Wachter R; Gröschel K
Stroke; 2019 Nov; 50(11):3077-3084. PubMed ID: 31537188
[TBL] [Abstract][Full Text] [Related]
3. Serum neurofilament light chain levels are associated with early neurological deterioration in minor ischemic stroke.
Li J; Zhang P; Zhu Y; Duan Y; Liu S; Fan J; Chen H; Wang C; Yi X
Front Neurol; 2023; 14():1096358. PubMed ID: 36970517
[TBL] [Abstract][Full Text] [Related]
4. Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke.
Onatsu J; Vanninen R; Jäkälä P; Mustonen P; Pulkki K; Korhonen M; Hedman M; Zetterberg H; Blennow K; Höglund K; Herukka SK; Taina M
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2242-2249. PubMed ID: 31151840
[TBL] [Abstract][Full Text] [Related]
5. Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection.
Traenka C; Disanto G; Seiffge DJ; Gensicke H; Hert L; Grond-Ginsbach C; Peters N; Regeniter A; Kloss M; De Marchis GM; Bonati LH; Lyrer PA; Kuhle J; Engelter ST
Cerebrovasc Dis; 2015; 40(5-6):222-7. PubMed ID: 26418549
[TBL] [Abstract][Full Text] [Related]
6. Serum neurofilament light chain in patients with acute cerebrovascular events.
De Marchis GM; Katan M; Barro C; Fladt J; Traenka C; Seiffge DJ; Hert L; Gensicke H; Disanto G; Sutter R; Peters N; Sarikaya H; Goeggel-Simonetti B; El-Koussy M; Engelter S; Lyrer PA; Christ-Crain M; Arnold M; Kuhle J; Bonati LH
Eur J Neurol; 2018 Mar; 25(3):562-568. PubMed ID: 29281157
[TBL] [Abstract][Full Text] [Related]
7. Association of serum biomarker neurofilament light concentration with post-stroke depression: A preliminary study.
Zhao H; Mo M; Miao C; Li L; Yang H; Liu Y; Yang G
Gen Hosp Psychiatry; 2020; 64():17-25. PubMed ID: 32078857
[TBL] [Abstract][Full Text] [Related]
8. Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction.
Pedersen A; Stanne TM; Nilsson S; Klasson S; Rosengren L; Holmegaard L; Jood K; Blennow K; Zetterberg H; Jern C
J Neurol; 2019 Nov; 266(11):2796-2806. PubMed ID: 31375988
[TBL] [Abstract][Full Text] [Related]
9. Serum Neurofilament Light Predicts Severity and Prognosis in Patients with Ischemic Stroke.
Wang P; Fan J; Yuan L; Nan Y; Nan S
Neurotox Res; 2020 Apr; 37(4):987-995. PubMed ID: 31898161
[TBL] [Abstract][Full Text] [Related]
10. Serum Neurofilament Light Chain as a Predictive Biomarker for Ischemic Stroke Outcome: A Systematic Review and Meta-analysis.
Liu D; Chen J; Wang X; Xin J; Cao R; Liu Z
J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104813. PubMed ID: 32305278
[TBL] [Abstract][Full Text] [Related]
11. The Association of Serum Neurofilament Light Chain and Acute Ischaemic Stroke Is Influenced by Effective Revascularization.
Zhou FY; Chen DW; Li HY; Zhu C; Shen YY; Peng ZY; Li L; Bu XL; Zeng GH; Zhang M; Wang YJ; Jin WS
Dis Markers; 2022; 2022():5236080. PubMed ID: 35557872
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament light chain levels predict encephalopathy and outcome in community-acquired pneumonia.
Chung HY; Wickel J; Oswald M; Dargvainiene J; Rupp J; Rohde G; Witzenrath M; Leypoldt F; König R; Pletz MW; Geis C;
Ann Clin Transl Neurol; 2023 Feb; 10(2):204-212. PubMed ID: 36479924
[TBL] [Abstract][Full Text] [Related]
13. Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes.
Bose G; Healy BC; Saxena S; Saleh F; Paul A; Barro C; Lokhande HA; Polgar-Turcsanyi M; Anderson M; Glanz BI; Guttmann CRG; Bakshi R; Weiner HL; Chitnis T
Mult Scler Relat Disord; 2023 Jun; 74():104695. PubMed ID: 37060852
[TBL] [Abstract][Full Text] [Related]
14. Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients.
Karteri S; Bruna J; Argyriou AA; Mariotto S; Velasco R; Alemany M; Kalofonou F; Alberti P; Dinoto A; Velissaris D; Stradella A; Cavaletti G; Ferrari S; Kalofonos HP
J Peripher Nerv Syst; 2022 Jun; 27(2):166-174. PubMed ID: 35384143
[TBL] [Abstract][Full Text] [Related]
15. Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke.
Vollmuth C; Fiessler C; Montellano FA; Kollikowski AM; Essig F; Oeckl P; Barba L; Steinacker P; Schulz C; Ungethüm K; Wolf J; Pham M; Schuhmann MK; Heuschmann PU; Haeusler KG; Stoll G; Otto M; Neugebauer H
Eur Stroke J; 2024 Feb; ():23969873241234436. PubMed ID: 38400734
[TBL] [Abstract][Full Text] [Related]
16. Serum neurofilament light chain in COVID-19 and the influence of renal function.
Körtvelyessy P; Diekämper E; Ruprecht K; Endres M; Stubbemann P; Kurth F; Graw JA; Menk M; Kuhle J; Wohlrab F
Eur J Med Res; 2023 Sep; 28(1):389. PubMed ID: 37770938
[TBL] [Abstract][Full Text] [Related]
17. Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
Altmann P; De Simoni D; Kaider A; Ludwig B; Rath J; Leutmezer F; Zimprich F; Hoeftberger R; Lunn MP; Heslegrave A; Berger T; Zetterberg H; Rommer PS
J Neuroinflammation; 2020 Mar; 17(1):86. PubMed ID: 32183837
[TBL] [Abstract][Full Text] [Related]
18. Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
Monreal E; Fernández-Velasco JI; García-Sánchez MI; Sainz de la Maza S; Llufriu S; Álvarez-Lafuente R; Casanova B; Comabella M; Ramió-Torrentà L; Martínez-Rodríguez JE; Brieva L; Saiz A; Eichau S; Cabrera-Maqueda JM; Villarrubia N; Espiño M; Pérez-Miralles F; Montalbán X; Tintoré M; Quiroga-Varela A; Domínguez-Mozo MI; Rodríguez-Jorge F; Chico-García JL; Lourido D; Álvarez-Cermeño JC; Masjuan J; Costa-Frossard L; Villar LM
JAMA Neurol; 2023 Apr; 80(4):397-403. PubMed ID: 36848127
[TBL] [Abstract][Full Text] [Related]
19. Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomes.
Amrein M; Meier S; Schäfer I; Schaedelin S; Willemse E; Benkert P; Walter J; Puelacher C; Zimmermann T; Median D; Egli C; Leppert D; Twerenbold R; Zellweger M; Kuhle J; Mueller C
Biomarkers; 2023 May; 28(3):341-351. PubMed ID: 36714921
[No Abstract] [Full Text] [Related]
20. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
Guasp M; Martín-Aguilar L; Sabater L; Bioque M; Armangué T; Martínez-Hernández E; Landa J; Maudes E; Borràs R; Muñoz-Lopetegi A; Saiz A; Castro-Fornieles J; Graus F; Parellada E; Querol L; Dalmau J
Neurology; 2022 Apr; 98(14):e1489-e1498. PubMed ID: 35145006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
